Assay Detail
Binding
CHEMBL928169
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of Flt3
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Confidence | 8 — Homologous single protein target |
| Curated By | Autocuration |
Target
Receptor-type tyrosine-protein kinase FLT3 (CHEMBL1974) ↗| Type | SINGLE PROTEIN |
| Organism | Homo sapiens |
Publication
Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 13 | 7.57 | 8.70 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL411903 | — | — | 1 | 8.70 |
| CHEMBL260092 | — | — | 1 | 8.70 |
| CHEMBL410731 | — | — | 1 | 8.52 |
| CHEMBL409872 | — | — | 1 | 8.22 |
| CHEMBL429516 | — | — | 1 | 8.15 |
| CHEMBL259013 | — | — | 1 | 8.05 |
| CHEMBL262607 | — | — | 1 | 7.89 |
| CHEMBL412102 | — | — | 1 | 7.80 |
| CHEMBL403706 | — | — | 1 | 6.87 |
| CHEMBL260848 | — | — | 1 | 6.84 |
| CHEMBL263374 | — | — | 1 | 5.57 |
| CHEMBL409839 | — | — | 1 | 5.54 |
| CHEMBL260093 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL411903 | — | IC50 | = | 2.0 | nM | 8.70 |
| CHEMBL260092 | — | IC50 | = | 2.0 | nM | 8.70 |
| CHEMBL410731 | — | IC50 | = | 3.0 | nM | 8.52 |
| CHEMBL409872 | — | IC50 | = | 6.0 | nM | 8.22 |
| CHEMBL429516 | — | IC50 | = | 7.0 | nM | 8.15 |
| CHEMBL259013 | — | IC50 | = | 9.0 | nM | 8.05 |
| CHEMBL262607 | — | IC50 | = | 13.0 | nM | 7.89 |
| CHEMBL412102 | — | IC50 | = | 16.0 | nM | 7.80 |
| CHEMBL403706 | — | IC50 | = | 135.0 | nM | 6.87 |
| CHEMBL260848 | — | IC50 | = | 145.0 | nM | 6.84 |
| CHEMBL263374 | — | IC50 | = | 2696.0 | nM | 5.57 |
| CHEMBL409839 | — | IC50 | = | 2858.0 | nM | 5.54 |
| CHEMBL260093 | — | IC50 | - | — | - |